The expression of circ-DGKB in blood was found to be of clinical importance in the diagnosis of NB by ROC analysis (AUC = 0.7778), with Kaplan-Meier analysis showing that patients with high levels of circ-DGKB expression had a lower survival rate (Yang et al., 2020). This evidence concerns the gene DGKB and neuroblastoma.